Medication info
Amerid M Tablet 2/500 mg

Amerid M Tablet 2/500 mg

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tabletMetformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Korea Prime Pharmaceutical Co., Ltd.
Appearance
White, elongated film-coated tablets
Packaging
30 tablets/box [(10 tablets/PTP X 3)]
Approval status
Active

MFDS item code 201200586 · Approved 2012.01.26 · Insurance code 663605180

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Administer this drug 1~2 times daily immediately before or with meals. The dose may be adjusted according to each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, and the dose may be adjusted based on the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose was glimepiride/metformin hydrochloride 2 mg/500 mg, and experience is available with gradual dose increases based on blood glucose monitoring up to glimepiride/metformin hydrochloride 8 mg/2000 mg. For glimepiride as a single agent, additional benefit is generally minimal at doses above 4 mg daily, although some patients achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). When used as an alternative to combination therapy, administer based on the dosage and administration of glimepiride and metformin hydrochloride currently being taken concomitantly. Do not take more than a single dose at the next scheduled administration, even if a previous dose was missed.

Ingredients

Manufacturer
Korea Prime Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication is prescribed to assist patients with type 2 diabetes in controlling their blood sugar levels, using Glimepiride and Metformin together. It is used in conjunction with dietary modifications and exercise therapy to effectively improve blood sugar management, helping to maintain stable blood sugar levels and reduce the risk of diabetes complications.

How to take

Adult dose

Administer this drug 1~2 times daily immediately before or with meals. The dose may be adjusted according to each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, and the dose may be adjusted based on the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose was glimepiride/metformin hydrochloride 2 mg/500 mg, and experience is available with gradual dose increases based on blood glucose monitoring up to glimepiride/metformin hydrochloride 8 mg/2000 mg. For glimepiride as a single agent, additional benefit is generally minimal at doses above 4 mg daily, although some patients achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). When used as an alternative to combination therapy, administer based on the dosage and administration of glimepiride and metformin hydrochloride currently being taken concomitantly. Do not take more than a single dose at the next scheduled administration, even if a previous dose was missed.

Precautions

This medication is used to lower blood sugar. It is essential to conduct kidney function tests before use, as this medication can accumulate in patients with impaired kidney function, potentially causing serious metabolic abnormalities such as lactic acidosis. If there are symptoms of dehydration, severe vomiting, diarrhea, or fever, the medication should be temporarily stopped, and a doctor should be consulted. Caution is also required when taking other medications that may affect kidney function. This medication is not to be administered to patients with insulin-dependent diabetes, acute metabolic acidosis, severe liver or kidney dysfunction, or to pregnant or breastfeeding women. Particular attention is required for elderly patients or those with poor nutritional status, or for those with irregular eating patterns or excessive alcohol consumption, as there is an increased risk of hypoglycemia. During treatment, patients should be well-informed about symptoms of hypoglycemia and lactic acidosis, and should notify their doctor immediately if these symptoms occur. Symptoms of hypoglycemia include headaches, severe hunger, dizziness, and drowsiness, while symptoms of lactic acidosis include muscle pain, weakness, and difficulty breathing. This medication may cause gastrointestinal disturbance symptoms (such as abdominal pain, diarrhea, nausea, etc.), most of which occur early in treatment and improve naturally over time. If symptoms are severe, dose adjustment may be necessary after consulting a physician. Regular monitoring of blood sugar, kidney function, and Vitamin B12 levels during treatment is required to check for any abnormalities, particularly as Vitamin B12 deficiency can occur and necessitates periodic monitoring. In cases of overdose, hypoglycemia or lactic acidosis may occur, requiring immediate medical intervention, and it is crucial to immediately consume sugar if hypoglycemia is experienced. Caution should be exercised against excessive alcohol consumption, as this medication may increase the risk of side effects when taken with alcohol. Pregnant or breastfeeding individuals should not take this medication and should be switched to insulin therapy as needed. To ensure children's safety, this medication should be stored out of reach of children, and caution is required when driving or operating machinery due to the risk of hypoglycemia or other side effects.

Side effects

Lactic acidosis, hypoglycemia, diarrhea, nausea, vomiting, abdominal distension, anorexia, dyspepsia, constipation, abdominal pain, metallic taste, visual impairment, taste disorder, erythema, pruritus, urticaria, thrombocytopenia, leukopenia, hemolytic anemia, anemia, granulocytopenia, agranulocytosis, pancytopenia, decreased vitamin B12, peripheral neuropathy, megaloblastic anemia, increased liver enzymes, liver damage, cholestasis, jaundice, hepatitis, allergic vasculitis, photosensitivity, decreased serum sodium concentration, decreased thyroid-stimulating hormone levels, magnesium deficiency in diarrhea, encephalopathy, hair loss, weight gain, palpitations, dizziness, leg edema, cardiac arrest, rectal carcinoma, benign prostatic hyperplasia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. It is important to maintain a storage temperature between 1 to 30 degrees Celsius to preserve the medication's effectiveness.

Appearance and packaging

Appearance

White, elongated film-coated tablets

Package unit

30 tablets/box [(10 tablets/PTP X 3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.